Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCGR | P47871 | 9/20 | 0.47 |
| ▸ | GIPR | P48546 | 9/20 | 0.47 |
| ▸ | PPARD | Q03181 | 1/20 | 0.47 |
| ▸ | DHODH | Q02127 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | RHOC | P08134 | 2/20 | 0.39 |
| ▸ | RHOA | P61586 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | GCG | P01275 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2665226 | 0.86 | FABP4 (0.43) | GCGRGIPRALDH1A1 | |
| SCHEMBL2665086 | 0.85 | GCGR (0.48) | GCGRGIPRPPARD | |
| SCHEMBL2665225 | 0.85 | GCGR (0.52) | GCGRGIPRDHODH | |
| SCHEMBL2665222 | 0.85 | KMT2A (0.41) | GCGRGIPREPHX2ALDH1A1 | |
| SCHEMBL2665224 | 0.84 | GCGR (0.43) | GCGRGIPRALDH1A1 | |
| SCHEMBL2647975 | 0.84 | GCGR (0.52) | GCGRGIPRDHODH | |
| SCHEMBL2655953 | 0.84 | GCGR (0.52) | GCGRGIPRDHODH | |
| SCHEMBL2647981 | 0.84 | GCGR (0.52) | GCGRGIPRDHODH | |
| SCHEMBL2655948 | 0.84 | GCGR (0.52) | GCGRGIPRDHODH | |
| SCHEMBL2665228 | 0.84 | GCGR (0.44) | GCGRGIPRPPARDEPHX2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003048109-A1 | NOVEL GLUCAGON ANTAGONISTS | NOVO NORDISK A/S (DK) | 2003-06-12 | — | — | WO | disclosed |